| 000 | 01841 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515015246.0 | ||
| 264 | 0 | _c20060502 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a0310-057X | ||
| 024 | 7 |
_a10.1177/0310057X0603400115 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWalsham, J | |
| 245 | 0 | 0 |
_aThe use of recombinant activated factor VII for refractory bleeding post complex cardiothoracic surgery. _h[electronic resource] |
| 260 |
_bAnaesthesia and intensive care _cFeb 2006 |
||
| 300 |
_a13-20 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCardiac Surgical Procedures _xadverse effects |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCoronary Care Units |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrainage _xmethods |
| 650 | 0 | 4 |
_aFactor VIIa _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHeart Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aLung Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostoperative Hemorrhage _xdiagnosis |
| 650 | 0 | 4 | _aQueensland |
| 650 | 0 | 4 | _aReoperation |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThoracic Surgical Procedures _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFraser, J F | |
| 700 | 1 | _aMullany, D | |
| 700 | 1 | _aZiegenfus, M | |
| 700 | 1 | _aChinthamuneedi, M | |
| 700 | 1 | _aDunning, J | |
| 700 | 1 | _aTesar, P | |
| 773 | 0 |
_tAnaesthesia and intensive care _gvol. 34 _gno. 1 _gp. 13-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0310057X0603400115 _zAvailable from publisher's website |
| 999 |
_c16105296 _d16105296 |
||